Faculty

Janey L. Wiggs, MD, PhD, Elected to the National Academy of Medicine

October 16, 2018

Janey Wiggs, MD, PhDJaney L. Wiggs, MD, PhD, the Paul A. Chandler Professor of Ophthalmology and Associate Director of the Ocular Genomics Institute at Harvard Medical School, and the Associate Chief for Clinical Research in Ophthalmology and Interim Glaucoma Service Director at Massachusetts Eye and Ear, has been elected to the prestigious National Academy of Medicine (NAM).

... Read more about Janey L. Wiggs, MD, PhD, Elected to the National Academy of Medicine

Botox May Improve Strabismus Surgery Success

May 14, 2018
In two companion studies—“The Effect of Botulinum Toxin Augmentation on Strabismus Surgery for Large-Angle Infantile Esotropia” and “Long-term Surgical Outcomes for Large-angle Infantile Esotropia”—just published in the American Journal of Ophthalmology, Boston Children’s Hospital (BCH) ophthalmologists Ankoor Shah, MD, PhD, David Hunter, MD, PhD, and colleagues in Boston collaborated with doctors at the Hospital for Sick Children in Toronto to provide new evidence that Botox can improve strabismus surgery success in children who have a very large angle of misalignment.... Read more about Botox May Improve Strabismus Surgery Success

Joan W. Miller, MD, Receives Howe Medal from American Ophthalmological Society

May 29, 2018

Joan W. Miller headhsotCelebrated award honors distinguished achievements in ophthalmology

Joan W. Miller, MD, the David Glendenning Cogan Professor and Chair of Ophthalmology at Harvard Medical School and Chief of Ophthalmology at Massachusetts Eye and Ear and Massachusetts General Hospital, has been named the 2018 recipient of the celebrated Lucien Howe Medal from the American Ophthalmological Society (AOS) for her distinguished service to the fields of retina and ophthalmology. ... Read more about Joan W. Miller, MD, Receives Howe Medal from American Ophthalmological Society

Researchers develop new class of antibiotics to fight leading superbugs

March 29, 2018

In a significant advance against drug-resistant superbugs, investigators supported by the Harvard-wide Program on Antibiotic Resistance have identified a new class of synthetic antibiotics that have been shown to be effective against Staphylococcus aureus and Enterococcus. The newly discovered antibiotics could one day help treat deadly infections caused by these superbugs.

The research group, which included Michael Gilmore, PhD, Sir William Osler Professor of...

Read more about Researchers develop new class of antibiotics to fight leading superbugs
Dr. Jason Comander

Mass. Eye and Ear performs first FDA-approved gene therapy procedure for inherited disease

March 20, 2018

Boston, Mass. — Massachusetts Eye and Ear made medical history on Tuesday by performing the first post-FDA approval gene therapy for patients with a form of inherited blindness. The occasion marks the beginning of a new era in medicine, as it is the first time any FDA-approved gene therapy has been given to a patient for any inherited disease.

The treatment, commercially identified as Luxturna, was developed by Spark Therapeutics and ...

Read more about Mass. Eye and Ear performs first FDA-approved gene therapy procedure for inherited disease

Pages